According to the Center for Disease Control, one in ten U.S. adults take antidepressants at any one time. For women in their 40’s and 50’s that number is one in four. The prescription of antidepressants in the U.S. has increased 400% since 1988. Sadly, antidepressants are effective for only around 30% of those who take them.
While qEEG shows great promise in predicting antidepressant medication response, and ending the need for lengthy “medication trials”, neurofeedback has been repeatedly found effective in activating brain areas responsible for depression, and helping people re-engage with life.
At Gray Matters, our use of qEEG to map brain function makes the depressed brain visible. We can see the brain areas that have become less active, reflecting the disengagement of the patient. More importantly, we can target these areas with neurofeedback to reactivate them, allowing the brain to normalize itself.